Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: August 18, 2017
Which patents cover Risedronate Sodium, and what generic Risedronate Sodium alternatives are available?
Risedronate Sodium is a drug marketed by Teva Pharms Usa, Macleods Pharms Ltd, Aurobindo Pharma Ltd, Apotex Inc, Mylan Pharms Inc, and Sun Pharma Global. and is included in nine NDAs.| Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 9 |
| Suppliers / Packagers: see list | 7 |
| Bulk Api Vendors: see list | 125 |
| Clinical Trials: see list | 2,450 |
| Patent Applications: see list | 3,042 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | RISEDRONATE SODIUM at DailyMed |
| Ingredient-type | Diphosphonates |
| Drug Class | Bisphosphonate |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 079215-001 | Jun 13, 2014 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Sun Pharma Global | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 090886-001 | Nov 30, 2015 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Aurobindo Pharma Ltd | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 200296-002 | Nov 30, 2015 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Macleods Pharms Ltd | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 203533-002 | Dec 9, 2015 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Teva Pharms Usa | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 077132-002 | Oct 5, 2007 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,341 others who get our Drug Patent Expiration Alerts:
